Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Increased frequency of activated cytotoxic T-lymphocytes in HIV infected patients facilitate HIV associated dementia
4th International Conference on Vaccines & Vaccination
September 24-26, 2014 Valencia Convention Centre, Spain

Gurleen and Sunil K Arora

Accepted Abstracts: J Vaccines Vaccin

Abstract:

Background: The advanced stage of HIV-1 disease may manifest into a variety of central nervous system disorders. The neurons may get damaged because of direct infection with the virus as well as indirectly due to the immune response. CD8 + Cytotoxic T-lymphocytes are proposed tobe responsible for HIV associated dementia, but the exact mechanisms have yet not been elucidated. Methodology: HIV + females with dementia score either <7.5 and non-demented HIV+ score >7.5 were recruited along with age matched healthy controls. Peripheral blood mononuclear cells were phenotyped for CTL markers along with CD127, CD45RA and CD45RO. CTLs expressing intracellular perforin and granzyme B were also enumerated. Among cytokines IFNγ and IL-7 levels estimated. The results were analyzed using appropriate statistical tools. Results: Among HAD group the mean CD4 count was 269 cells/μL, and viral load 19095 copies/ml, while the non-demented individuals had normal CD4 count of 485 cells/μL with lower quantity of viral RNA (7527 copies/ml). The HAD group had significantly lower number (9.8%) of CD4 + CD127 + cells compared to 17.04% in ND group and 32.18% in HCs. The frequency of CTLs expressing CD127 was 14.34% among demented individuals as compared to 18.67% in non-demented patients. The significantly higher proportion of CTLs from HAD patients expressed Granzyme B and Perforin (59.4+20.9 and 34.05+19.09 respectively) as compared to non-demented patients (47.5+19.55 and 26.94+16.17). The dementia score was significantly correlated with the frequency of CD8 + cells expressing Granzyme B indicating a direct association. Conclusions: The findings suggest that the proliferation of terminally differentiated and activated CD8 + cells in the HIV patients with prolonged disease, may be associated with enhanced killing of neuronal cells leading to dementia.